ConductScience.org, home
OTOR: otoraplin
API referenceFor AI assistants

Gene · 56914

Papers1,445

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 1,445

Download this page as JSON
TitleJournalYearPMIDFound bySource
The impact of chemoimmunotherapy on primary cold agglutinin disease and Waldenström macroglobulinemia-associated cold agglutinin syndrome.Front Med (Lausanne)202642755913PubTator, text miningPubMed
Fibrin Degradation Products Regulate Endothelial Barrier Function in Traumatic Brain Injury via the Actin Cytoskeleton.Neurotrauma Rep202642666666PubTator, text miningPubMed
Fibrin degradation products enhance plasmin activity and contribute to fibrinolysis during simulated trauma-induced coagulopathy.Blood Coagul Fibrinolysis202642083375PubTator, text miningPubMed
Analyzing Misinformation and Disinformation: Understanding Swiss COVID-19 Narratives Through Natural Language Processing Analysis.JMIR Infodemiology202641911325PubTator, text miningPubMed
Flexor Tendon Repair Using a New Looped Six- and Eight-Strand Technique-A Biomechanical Analysis.J Pers Med202641893012PubTator, text miningPubMed
Fibrinogen-Bmal1 signaling as a therapeutic target to limit aortic dissection by preserving VSMC contractility.Signal Transduct Target Ther202641856973PubTator, text miningPubMed
Analysis of clinical features of AECOPD at different altitudes and GOLD stages in high-altitude regions.BMJ Open Respir Res202641825891PubTator, text miningPubMed
Establishment of Age-Specific Reference Intervals for 16 Coagulation Parameters in Chinese Children Using Sysmex CN-6000 Analyzer: A Cross-Sectional Study.Health Sci Rep202641822764PubTator, text miningPubMed
Preparation of Felodipine-PEG Solid Dispersions by Solvent-Free scCO2 Processing and Their Translation into Orally Disintegrating Tablets.ACS Omega202641768666PubTator, text miningPubMed
Successful Management of Suspected Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in BRAF-Mutant Cholangiocarcinoma Following Treatment With Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors: A Case Report.
Cancer Rep (Hoboken)202641761754PubTator, text miningPubMed
Efficacy and Safety of Low-Dose Prolonged Infusion Thrombolysis With rt-PA for Acute Intermediate-High Risk Pulmonary Embolism.Pulm Circ202641756747PubTator, text miningPubMed
Retraction Note: Elevated FDP levels independently predict poor outcomes in HBV-ACLF patients treated with artificial liver support system therapy.Sci Rep202641730973PubTator, text miningPubMed
Attritional Carpal Dislocation and Flexor Tendon Rupture as a Rare Complication of Conservatively Managed Distal Radius Fracture in a Rheumatoid Patient.J Hand Surg Glob Online202641717325PubTator, text miningPubMed
Targeted Muscle Reinnervation in Wartime Amputation: A Review of Pediatric Literature and Feasibility in Current Conflicts.Plast Reconstr Surg Glob Open202641716609PubTator, text miningPubMed
Maternal death due to placenta percreta: a case report study.Int J Emerg Med202641714927PubTator, text miningPubMed
Evaluation of artificial intelligence identified ipratropium bromide for the treatment of coronavirus disease 2019.Sci Rep202641714644PubTator, text miningPubMed
Immune checkpoint inhibitors combined with chemotherapy enhance coagulation activation and elevate venous thromboembolism risk in non-small cell lung cancer.Am J Cancer Res202641657802PubTator, text miningPubMed
A machine learning-based prediction model for poor prognosis in sepsis using lymphocyte count: a national, multicenter prospective cohort.Sci Rep202641571726PubTator, text miningPubMed
Neutrophil Extracellular Traps and DNase Activity in Sepsis: Associations with Coagulopathy and Organ Dysfunction.Clin Appl Thromb Hemost202641568992PubTator, text miningPubMed
Study on Deep Vein Thrombosis Incidence and Risk Factors in Orthopedic Trauma Patients with Chronic Hepatitis B: 579 Cases Analyzed.Clin Appl Thromb Hemost202641564263PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/56914/papers

API referenceFor AI assistants